Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 26 May 2025

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system

in Pharmacoepidemiology

Haolin Teng
Shengnan Zhang
Jinyu Yu
Faping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1518258

3,215 views
2 citations

Original Research

Published on 22 May 2025

Prevalence and factors associated with Chinese herbal medicine use among middle-aged and older Chinese adults with diabetes mellitus

in Pharmacoepidemiology

Yanting Chen
Leying Lin
Shanwei Sun
Kaiwang Cui
Qingrong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1482228

3,138 views

Systematic Review

Published on 22 May 2025

A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations

in Pharmacoepidemiology

Pierluigi Navarra
Luca Buzzonetti
Valentina Amico
Melina Cro
Bruno Federico

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1497667

6,267 views

Original Research

Published on 22 May 2025

Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin

in Pharmacoepidemiology

Pei Zhang
Qiong Chen
Jiahui Lao
Juan Shi
Jia Cao
Xiao Li
Xin Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538074

2,569 views
8 citations

Original Research

Published on 21 May 2025

Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects

in Pharmacoepidemiology

Anaelle Weissgerber
Maren Hermanns-Clausen
Evelyn Lamy

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571025

4,471 views
2 citations

Original Research

Published on 20 May 2025

Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

in Pharmacoepidemiology

Rafael Nogueira de Souza
Marília Berlofa Visacri
Fabiana Bragança Albanese Trotta
Deise de Souza Ventura
Mauricio Wesley Perroud
Patrícia Moriel

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514942

2,434 views

Original Research

Published on 20 May 2025

Enhancing medication appropriateness: Insights from the STOPP (Screening Tool of Older Persons’ Prescriptions) criteria version 3 on prescribing practices among the older adults in Pakistan

in Pharmacoepidemiology

Halima Sadia
Safila Naveed
Hina Rehman
Shazia Jamshed
Huma Dilshad

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551819

3,021 views

Original Research

Published on 16 May 2025

Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database

in Pharmacoepidemiology

Bingqing Wang
Kaidi Zhao
Ningyi Xian
Landong Ren
Jiashu Liu
Chen Tu
Dewu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1497708

4,077 views
2 citations

Original Research

Published on 14 May 2025

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

in Pharmacoepidemiology

Yuan-Yuan Wu
Qiong-Lian Huang
Zhan-Yang Luo
Xiao-Yun Song
You-Yang Shi
Jin-Zhou Zheng
Sheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529342

4,145 views
3 citations

Original Research

Published on 13 May 2025

Time-dependent impact of immunosuppressant regimens on cardiovascular outcomes in kidney transplant recipients: a nationwide cohort study

in Pharmacoepidemiology

Jinhyun Park
Wonhui Choi
Jinseub Hwang
Young-Mi Ah
Byung Ha Chung
Yun-Kyoung Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540576

2,350 views

Original Research

Published on 12 May 2025

Drug stockpiling behavior and its impact on anxiety among the general public in the early stage after the lifting of China’s Zero-COVID policy: results from a web-based survey

in Pharmacoepidemiology

Yu Huang
Shuiyang Xu
Xiang Zhao
Lei Wang
Qiaohong Lv
Suxian Wu
Qingqing Wu
Xuehai Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524068

1,813 views
1 citation

Original Research

Published on 09 May 2025

Construction and validation of a meropenem-induced liver injury risk prediction model: a multicenter case-control study

in Pharmacoepidemiology

Yan He
Hongqin Ke
Jianyong Zhu
Xin Yuan
Hongliang Li
Wenwen Wu
Shuman Yang
Huibin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1542554

2,827 views
2 citations

Original Research

Published on 06 May 2025

Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: a retrospective examination of real-world cohort

in Pharmacoepidemiology

Aseel Sukik
Ahmed Tarek Aboughalia
Abdul Haseeb Said Wali
Amro Al Radaideh
Omar Mohamed Elsayed
Mohammed A. Amer
Joud Said Abuodeh
Oyelola A. Adegboye
AbdelNaser Elzouki
Mohammed Ibn-Mas‘ud Danjuma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526112

2,908 views

Original Research

Published on 06 May 2025

Adherence and persistence with istradefylline treatment in patients with Parkinson’s disease in the United States

in Pharmacoepidemiology

Reversa Joseph
Joyce Qian
Hannah Cummings
Yen-Hua Chen
Shubham Tewari
Michael Soileau

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548631

3,601 views

Original Research

Published on 02 May 2025

An in-depth exploration of the association between olanzapine, quetiapine and acute pancreatitis based on real-world datasets and network toxicology analysis

in Pharmacoepidemiology

Shuang Wang
Liying Song
Yuanjie Sun
Haonan Zhou
Jia Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529416

6,047 views
1 citation

Original Research

Published on 02 May 2025

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system

in Pharmacoepidemiology

Liangxia Li
Qianqian Xu
Liangfang Pang
Yarui Liu
Yuanyuan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519865

6,109 views
4 citations

Original Research

Published on 30 Apr 2025

Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system

in Pharmacoepidemiology

Hao Liu
Wei Yan
Jinsong Li
Dezhi Yan
Di Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1483669

5,017 views
5 citations

Original Research

Published on 30 Apr 2025

Drug-associated infections and infestations in older adults with tumor necrosis factor-alpha inhibitors: a real-world retrospective and pharmacovigilance study

in Pharmacoepidemiology

Xihui Yu
Jiahong Zhong
Xuemei Zhuang
Zhuomiao Lin
Hongbo Fu
Yaofeng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533902

5,368 views
2 citations

Original Research

Published on 28 Apr 2025

Prescribing characteristics and guideline concordance of antihypertensive western and Chinese patent medicine in Internet hospitals in China: a cross-sectional study

in Pharmacoepidemiology

Tiantian Zhou
Xing Liao
Jiaxin Zuo
Fang Han
Ruogu Meng
Lin Zhuo
Guozhen Liu
Jing Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1580787

3,366 views

Original Research

Published on 28 Apr 2025

Charting the COVID-19 vaccination journey in Saudi Arabia: Insights into post-vaccination adverse effects and immunization dynamics

in Pharmacoepidemiology

Gehad M. Subaiea
Nawaf Alkhateeb
Faisal Sahman
Abdulrahman Alsudayri
Abdulkarim M. Almudayni
Hamoud Alrashidi
Abdulrahman M Alshammari
Abdulwahab Alamri
Sultan Almuntashiri
Arshad Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561410

2,164 views
2 citations

Original Research

Published on 28 Apr 2025

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases

in Pharmacoepidemiology

Tao Wang
Zhiwei Cui
Yingyong Ou
Siyu Lou
Huayou Chen
Chengyu Zhu
Linmei Zhou
Fan Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530697

5,891 views
7 citations

Original Research

Published on 25 Apr 2025

Acute liver injury and diffuse subcutaneous pneumatosis following compound paracetamol and amantadine hydrochloride tablets poisoning: a case report

in Pharmacoepidemiology

Zhiwen Zhao
Bo Wang
Lanlan Cai
Xuefang Liu
Zhicheng Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1503449

22,612 views
2 citations

Systematic Review

Published on 25 Apr 2025

Evaluating the efficacy of valproic acid in alcohol use disorder: a systematic analysis of clinical trials from ClinicalTrials.gov

in Pharmacoepidemiology

Fahad S. Alshehri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1503035

4,558 views

Original Research

Published on 24 Apr 2025

Real-world pharmacovigilance analysis of drug-related cataracts using the FDA adverse event reporting system database

in Pharmacoepidemiology

Xiang Li
Shu Wen Wang
Zhi-Jie Zhang
Zhan Yang Luo
Jia Feng Tang
Tao Tao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1498191

3,915 views
5 citations

602 articles

articles

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system

Prevalence and factors associated with Chinese herbal medicine use among middle-aged and older Chinese adults with diabetes mellitus

A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations

Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin

Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects

Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

Enhancing medication appropriateness: Insights from the STOPP (Screening Tool of Older Persons’ Prescriptions) criteria version 3 on prescribing practices among the older adults in Pakistan

Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

Time-dependent impact of immunosuppressant regimens on cardiovascular outcomes in kidney transplant recipients: a nationwide cohort study

Drug stockpiling behavior and its impact on anxiety among the general public in the early stage after the lifting of China’s Zero-COVID policy: results from a web-based survey

Construction and validation of a meropenem-induced liver injury risk prediction model: a multicenter case-control study

Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: a retrospective examination of real-world cohort

Adherence and persistence with istradefylline treatment in patients with Parkinson’s disease in the United States

An in-depth exploration of the association between olanzapine, quetiapine and acute pancreatitis based on real-world datasets and network toxicology analysis

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system

Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system

Drug-associated infections and infestations in older adults with tumor necrosis factor-alpha inhibitors: a real-world retrospective and pharmacovigilance study

Prescribing characteristics and guideline concordance of antihypertensive western and Chinese patent medicine in Internet hospitals in China: a cross-sectional study

Charting the COVID-19 vaccination journey in Saudi Arabia: Insights into post-vaccination adverse effects and immunization dynamics

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases

Acute liver injury and diffuse subcutaneous pneumatosis following compound paracetamol and amantadine hydrochloride tablets poisoning: a case report

Evaluating the efficacy of valproic acid in alcohol use disorder: a systematic analysis of clinical trials from ClinicalTrials.gov

Real-world pharmacovigilance analysis of drug-related cataracts using the FDA adverse event reporting system database